Creative Medical Technology Holdings, Inc. balance sheet
At the end of fiscal 2025, Creative Medical Technology Holdings, Inc. had total assets of $7.8m, total liabilities of $284,880 and shareholders' equity of $7.5m. It held $7.2m in cash against $0 of debt: net cash of $7.2m.
Balance sheet
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 8 | 3 | 6 | 7 | 9 |
| Receivables | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 19 | 10 | 6 | 7 | 9 |
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 11 | 19 | 11 | 7 | 8 | 9 |
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 0 | 1 |
| Total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 9 | 41 | 1 | 3 | 0 | 0 | 0 | 1 |
| Long-term debt | — | — | — | — | — | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | — | — | — | 0 | 0 | 0 | 2 | 4 | 9 | 41 | 1 | 3 | 0 | 0 | 0 | 1 |
| Shareholders' equity | −0 | −0 | −0 | −0 | −0 | 0 | −0 | −2 | −4 | −8 | −40 | 10 | 16 | 10 | 6 | 8 | 9 |
| Net debt (negative = net cash) | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 0 | 0 | 2 | 2 | −10 | −8 | −3 | −6 | −7 | −9 |
| Shares outstanding | 18m | 127m | 127m | 127m | 127m | 128m | 105m | 115m | — | — | — | — | — | 1m | 2m | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Inventory | 3 | 2 | 1 | 1 | 1 | 0 | 125 | 125 |
| Total current assets | 6,331 | 6,135 | 7,844 | 6,633 | 5,412 | 7,399 | 6,059 | 9,019 |
| Total assets | 6,888 | 6,669 | 8,347 | 7,105 | 5,853 | 7,810 | 6,441 | 9,378 |
| Accounts payable | 274 | 274 | 272 | 263 | 247 | 271 | 293 | 684 |
| Total current liabilities | 331 | 328 | 286 | 278 | 261 | 285 | 308 | 699 |
| Total liabilities | 331 | 328 | 286 | 278 | 261 | 285 | 308 | 699 |
| Shareholders' equity | 6,557 | 6,341 | 8,061 | 6,828 | 5,592 | 7,515 | 6,110 | 8,655 |
| Shares outstanding | 1m | 2m | 3m | 3m | 3m | 4m | 4m | 6m |
Compare with peers
- Lyell Immunopharma, Inc. balance sheet
- AIM Immunotech Inc. balance sheet
- Ibio, Inc. balance sheet
- Lisata Therapeutics, Inc. balance sheet
- Celldex Therapeutics, Inc. balance sheet
Head to head: CELZ vs LYELAIM vs CELZCELZ vs IBIO
More: Biotechnology stocks compared, Health Care sector, rankings of US companies